Sonora Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Sonora Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$43K	Buy	560 +100	+22%	+$7.89K	0.01%	443
2021 Q2	$38K	Hold	460	–	–	0.01%	447
2021 Q1	$35K	Hold	460	–	–	﹤0.01%	716
2020 Q4	$40K	Hold	460	–	–	﹤0.01%	686
2020 Q3	$35K	Sell	460 -490	-52%	-$49.6K	﹤0.01%	684
2020 Q2	$117K	Buy	950 +450	+90%	+$44.7K	0.01%	308
2020 Q1	$42K	Hold	500	–	–	0.01%	540
2019 Q4	$42K	Sell	500 -28	-5%	-$2.12K	﹤0.01%	612
2019 Q3	$36K	Sell	528 -172	-25%	-$13.2K	﹤0.01%	626
2019 Q2	$60K	Hold	700	–	–	0.01%	451
2019 Q1	$62K	Buy	700 +200	+40%	+$18.5K	0.01%	414
2018 Q4	$43K	Hold	500	–	–	0.01%	431
2018 Q3	$48K	Sell	500 -100	-17%	-$9.98K	0.01%	425
2018 Q2	$57K	Hold	600	–	–	0.01%	360
2018 Q1	$48.6K	Hold	600	–	–	0.01%	403
2017 Q4	$53.5K	Hold	600	–	–	0.01%	386
2017 Q3	$55.8K	Hold	600	–	–	0.01%	329
2017 Q2	$54.5K	Hold	600	–	–	0.01%	322
2017 Q1	$52.7K	Hold	600	–	–	0.01%	328
2016 Q4	$49.7K	Sell	600 -50	-8%	-$4.3K	0.01%	296
2016 Q3	$60.1K	Hold	650	–	–	0.01%	273
2016 Q2	$50.6K	Sell	650 -25	-4%	-$2.13K	0.01%	268
2016 Q1	$60.9K	Hold	675	–	–	0.01%	260
2015 Q4	$71K	Hold	675	–	–	0.02%	190
2015 Q3	$85K	Buy	+675	New	+$90.2K	0.03%	161

Other funds holding BMRN

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sonora Investment Management's BMRN Position: Q3 2021 in Review

Sonora Investment Management increased its BioMarin Pharmaceuticals (BMRN) stake by 22% in Q3 2021, buying an estimated $7.89K and bringing the position to 560 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #443.

Sonora Investment Management first reported a position in BMRN in Q3 2015 and has held it in 25 quarters since. The position peaked at $117K in Q2 2020. 512 funds tracked by Wall St. Rank hold BMRN as of Q3 2021.

Sonora Investment Management held 560 shares of BioMarin Pharmaceuticals worth $43K as of Q3 2021.
Sonora Investment Management bought 100 BioMarin Pharmaceuticals shares in Q3 2021, an estimated $7.89K.
BioMarin Pharmaceuticals made up 0.01% of Sonora Investment Management's portfolio in Q3 2021, its #443 holding.
Sonora Investment Management first reported a position in BioMarin Pharmaceuticals in Q3 2015 and has held it in 25 quarters since.
Sonora Investment Management's BioMarin Pharmaceuticals position peaked at $117K in Q2 2020.
512 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.